Novartis Has A New Goal: $2bn Peak Sales Per Product

Narrow
Novartis is narrowing its pipeline focus to prioritize higher value assets • Source: Shutterstock
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

More from R&D

More from Scrip